UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                             -----------------------

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of The
                         Securities Exchange Act of 1934

         Date of report (Date of earliest event reported): July 12, 2006

                            HEALTHRENU MEDICAL, INC.
             (Exact name of registrant as specified in its charter)

  Nevada                                   000-21914          25-1907744
---------------------------------        -------------      --------------------
(State or other jurisdiction of          (Commission        (IRS Employer
incorporation)                           File Number)       Identification No.)

          12777 Jones Road, Suite 481, Houston, TX                 77070
          ----------------------------------------                 -----
        (Address of Principal Executive Offices)                 (Zip Code)

            Our telephone number, including area code: (281)_890-2561
                                                       ---------------

                                 Not Applicable
                -------------------------------------------------

          (Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing  obligation  of us under any of the following
provisions (see General Instruction A.2. below):

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

|_| Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))

<PAGE>
                            Section 8 - Other Events

Item 8.01    Other Events

As of July 12,  2006,  the OTC  Bulletin  Board  ("OTCBB")  ceased  quoting  the
Company's  shares on the OTCBB.  The Company's  common stock will continue to be
quoted  through  various market makers on the Pink Sheets  Electronic  Quotation
Service published by the National  Quotation Bureau under the symbol "HRUM". The
Pink Sheets is a  centralized  quotation  service that  collects  and  publishes
market maker quotations of securities.

The Company had not timely filed with the  Securities  and  Exchange  Commission
("SEC")  financial  statements  for the  fiscal  quarter  ended  March 31,  2006
reviewed by the Company's  independent public accountant.  The Company had filed
with the SEC financial  statements  for the fiscal  quarter ended March 31, 2006
which were not reviewed by the Company's independent public accountant.

The review of the Company's  financial  statements  for the fiscal quarter ended
March 31, 2006 was  completed  and the  Company  filed such  reviewed  financial
statements  with the SEC on July 11, 2006 (with a filing date of July 12, 2006),
however,  such filing was not made in sufficient  time to prevent the OTCBB from
ceasing to quote the Company's shares.  Upon such filing, the Company's stock is
again  eligible  for  quotation  on  the  OTCBB  and  the  Company  is  pursuing
reinclusion of its share quoatations on the OTCBB.

The filing of the reviewed financial statements was delayed because the Company,
in consultation with its independent public accountant, determined in connection
with the preparation of the Company's  March 31, 2006 financial  statements that
the debt  financings  conducted by the Company  during August and September 2005
and  February   2006  required   reevaluation   as  a  result  of  evolving  SEC
interpretations  of the accounting  rules relating to various  convertible  debt
instruments,  which include embedded  derivatives.  The Company has been working
with a  professional  accounting  firm in an effort to  expedite  and assist the
independent  public  accountant in connection with its review of these financing
transactions.


                                       2
<PAGE>

                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934, we
have duly caused this report to be signed on our behalf by the undersigned
hereunto duly authorized.

Date:  July 12, 2006

                                       HEALTHRENU MEDICAL, INC.
                                       (Registrant)

                                       By: /s/ Robert W. Prokos
                                           -------------------------------------
                                           Name:  Robert W. Prokos
                                           Title: President and
                                           Chief  Executive Officer

                                       3
{"company-data": {"conformed-name": "HEALTHRENU MEDICAL INC", "cik": "0000791118", "assigned-sic": "2844", "irs-number": "841022287", "state-of-incorporation": "CO", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-21914", "film-number": "06957801"}, "business-address": {"street1": "7255 E. QUINCY AVENUE", "street2": "SUITE 550", "city": "DENVER", "state": "CO", "zip": "80237", "phone": "303-437-9434"}, "mail-address": {"street1": "P O BOX 620", "city": "TAMPA", "state": "FL", "zip": "33601"}, "former-company": [{"former-conformed-name": "AGTSPORTS INC", "date-changed": "19930616"}, {"former-conformed-name": "ULTRATECH KNOWLEDGE SYSTEMS INC", "date-changed": "19920703"}, {"former-conformed-name": "AMERICAN MERGER CONTROL INC /CO/", "date-changed": "19900823"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                             -----------------------

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of The
                         Securities Exchange Act of 1934

         Date of report (Date of earliest event reported): July 12, 2006

                            HEALTHRENU MEDICAL, INC.
             (Exact name of registrant as specified in its charter)

  Nevada                                   000-21914          25-1907744
---------------------------------        -------------      --------------------
(State or other jurisdiction of          (Commission        (IRS Employer
incorporation)                           File Number)       Identification No.)

          12777 Jones Road, Suite 481, Houston, TX                 77070
          ----------------------------------------                 -----
        (Address of Principal Executive Offices)                 (Zip Code)

            Our telephone number, including area code: (281)_890-2561
                                                       ---------------

                                 Not Applicable
                -------------------------------------------------

          (Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing  obligation  of us under any of the following
provisions (see General Instruction A.2. below):

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

|_| Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Section 8 - Other Events

Item 8.01    Other Events

As of July 12,  2006,  the OTC  Bulletin  Board  ("OTCBB")  ceased  quoting  the
Company's  shares on the OTCBB.  The Company's  common stock will continue to be
quoted  through  various market makers on the Pink Sheets  Electronic  Quotation
Service published by the National  Quotation Bureau under the symbol "HRUM". The
Pink Sheets is a  centralized  quotation  service that  collects  and  publishes
market maker quotations of securities.

The Company had not timely filed with the  Securities  and  Exchange  Commission
("SEC")  financial  statements  for the  fiscal  quarter  ended  March 31,  2006
reviewed by the Company's  independent public accountant.  The Company had filed
with the SEC financial  statements  for the fiscal  quarter ended March 31, 2006
which were not reviewed by the Company's independent public accountant.

The review of the Company's  financial  statements  for the fiscal quarter ended
March 31, 2006 was  completed  and the  Company  filed such  reviewed  financial
statements  with the SEC on July 11, 2006 (with a filing date of July 12, 2006),
however,  such filing was not made in sufficient  time to prevent the OTCBB from
ceasing to quote the Company's shares.  Upon such filing, the Company's stock is
again  eligible  for  quotation  on  the  OTCBB  and  the  Company  is  pursuing
reinclusion of its share quoatations on the OTCBB.

The filing of the reviewed financial statements was delayed because the Company,
in consultation with its independent public accountant, determined in connection
with the preparation of the Company's  March 31, 2006 financial  statements that
the debt  financings  conducted by the Company  during August and September 2005
and  February   2006  required   reevaluation   as  a  result  of  evolving  SEC
interpretations  of the accounting  rules relating to various  convertible  debt
instruments,  which include embedded  derivatives.  The Company has been working
with a  professional  accounting  firm in an effort to  expedite  and assist the
independent  public  accountant in connection with its review of these financing
transactions.

                                       2
SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934, we
have duly caused this report to be signed on our behalf by the undersigned
hereunto duly authorized.

Date:  July 12, 2006

                                       HEALTHRENU MEDICAL, INC.
                                       (Registrant)

                                       By: /s/ Robert W. Prokos
                                           -------------------------------------
                                           Name:  Robert W. Prokos
                                           Title: President and
                                           Chief  Executive Officer

                                       3